{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7no8wIDA","lastupdate":"2022-12-18T00:00:00.000Z","update_date":"2022-12-18T00:00:00.000Z","lastModified":"Mar 14, 2025","active":1,"confidence_score":100,"confidence_score_reason":"markets","urlname":"spacepharma","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$exvZr7H7eQqEObo1yyfvBbAV9CVDN9OnfOvtn0B420HTKUDe25gBgE","name":"SpacePharma","oneliner":"Microgravity Assays for R&D Pipelines","registrar":"514884238","website":"https://www.spacepharma.health","careerspage":"","founded_month":6,"founded_year":2013,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/sp_microgravity","youtube":"https://www.youtube.com/user/SpacePharma","facebook":"https://www.facebook.com/Spacepharma","linkedin":"https://www.linkedin.com/company/10408185","instagram":""},"social":["https://twitter.com/sp_microgravity","https://www.youtube.com/user/SpacePharma","https://www.linkedin.com/company/10408185","https://www.facebook.com/Spacepharma"],"flattenedsociallinks":"https://twitter.com/sp_microgravity|https://www.youtube.com/user/SpacePharma|https://www.linkedin.com/company/10408185|https://www.facebook.com/Spacepharma","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":24,"patent":0,"raised":19980000,"stage":"A","public_stage":"A","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Space.Pharma","Space Pharma","Space-Pharma"],"about":"SpacePharma is focused on using microgravity, or virtual weightlessness, for research and development. The company has developed end-to-end miniaturized lab systems, equipped with sensors and readers, capable of working on different microgravity platforms. \n\nThe company has introduced mGnify, a miniaturized end-to-end lab that can be remotely controlled from anywhere and used with different microgravity platforms, including SpacePharma’s nanosatellites.\n\nSpacePharma assists its customers in all phases of performing experiments in microgravity, including experiment planning, preparation, execution in microgravity, and result analysis.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97298668332","country":null,"address":{"israeli":[{"id":"a9ec008c-76d2-465f-8bcc-c483a42a47cd","city":"Herzliya","type":null,"address":"Abba Eban Boulevard 1, Herzliya, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"00eb4c5e-3c02-4c39-8cd2-f6c8fd3dc99a","city":"Merritt Island","address":"505 Odyssey Way, Merritt Island, Florida, USA","country":"United States","placeid":null},{"id":"041cc8e7-ab3a-4bd5-bfcb-7371104d5609","city":"Courgenay","address":" Rue l'Armeratte 3, 2950 Courgenay, Switzerland","country":"Switzerland","placeid":null},{"id":"80b24ae6-384a-4e86-8d26-01ef2471a914","city":"Palo Alto","address":"237 Washington Ave, Palo Alto, CA, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"b44055f7-51b6-41bd-a590-a39c711ead48","date":"Jan 12, 2022","link":"https://chiportal.co.il/%D7%99%D7%95%D7%A1%D7%99-%D7%99%D7%9E%D7%99%D7%9F-%D7%9E%D7%A0%D7%9B%D7%9C-space-pharma-%D7%A4%D7%99%D7%AA%D7%97%D7%A0%D7%95-%D7%9E%D7%97%D7%A9%D7%91-%D7%97%D7%9C%D7%9C-%D7%99%D7%99%D7%A2%D7%95/?_atscid=7_134353_204082920_2086569_0_Txtetaxjxdshwhus8sp","source":"chiportal.co.il","visible":1,"analysis":{"tags":"Space Technology, Biotech","company":"SpacePharma","layoffs":"N/A","summary":"Israeli start-up SpacePharma has developed a computer for conducting biological experiments in space. The computer, based on off-the-shelf components and a Raspberry Pi card, is manufactured in Israel by Nisko and is much cheaper than other space computers. The companys biological lab, which weighs only about four kilograms, is currently concluding its operation at the International Space Station. The lab, which was launched last month on SpaceXs CRS-24 mission, will return to Earth on a SpaceX Dragon spacecraft, allowing the Israeli team to examine how the system withstood space conditions.","partners":["SpaceX","SpaceApps"],"customers":"N/A","investors":"N/A","confidence":8,"key_topics":["Space Lab","Biological Experiments","SpaceX","Raspberry Pi","Space Conditions"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Customers","Partners"],"acquisition_amount":"N/A","structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"NXTnG4SaZY2iPJDLrMuZyUBigpKQXpvandwYHhp9XXxSCQfOPaXshx","news_summary":"יוסי ימין, מנכ\"ל Space Pharma: פיתחנו מחשב חלל ייעודי לניסויים ביולוגיים - Chiportal","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"261e5ffd-5517-4913-a74b-6ca1b65b4315","date":"Dec 26, 2021","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3925795,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"nanotechnology, cancer treatment","company":"Ayana Pharma","layoffs":null,"summary":"Israeli company Ayana Pharma has developed a nanotechnology cancer treatment drug called Doxil, which has received FDA approval. The drug is being tested under zero-gravity conditions in a smart laboratory developed by SpacePharma and launched aboard Elon Musks Falcon 9 launcher. The purpose of the experiment is to determine if the drugs physical properties and activity against cancer cells are affected by non-gravity conditions. The development of Doxil was led by Prof. Yehezkel Bernholtz of the Hebrew University. Ayana Pharmas main investors include the Education fund for teachers and kindergarten teachers in Israel, the Integra Holdings Fund, the Ilan Holdings Fund, and Dr. Shmuel Kabili.","partners":["SpacePharma"],"customers":null,"investors":["Education fund for teachers and kindergarten teachers in Israel","Integra Holdings Fund","Ilan Holdings Fund","Dr. Shmuel Kabili"],"confidence":9,"key_topics":["nanotechnology","cancer treatment","zero-gravity","drug development","space testing"],"date_of_event":"2021-12-26","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"9IyWhUQ4AOEFstNhUNoVGk4Cw08JUY45EijSaEcXM2PyTcogjLSHjB","news_summary":"Israeli companies send nanotechnology cancer treatment experiment to space aboard SpaceX","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2d2ae1a0-4497-4df6-812c-2c31941527b4","date":"Sep 3, 2020","link":"https://en.globes.co.il/en/article-spacepharma-mini-lab-launched-in-italy-israel-collaboration-1001341647","source":"en.globes.co.il","visible":1,"analysis":{"tags":"space mission","company":"SpacePharma","layoffs":null,"summary":"Israeli-Italian nano-satellite Dido III, developed by SpacePharma, was launched with an automated mini-laboratory for medical experiments. The experiments will be conducted under weightless conditions to provide unique information. The results will be transmitted to SpacePharmas ground station in Switzerland. SpacePharma has previously conducted space missions and experiments under weightlessness. State of Mind Ventures is one of the investors in SpacePharma.","partners":null,"customers":null,"investors":"State of Mind Ventures","confidence":9,"key_topics":["nano-satellite","automated lab","medical experiments","weightlessness","research"],"date_of_event":"September 3, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"QCPFJjTSKpqzp2Qw77z9hVbYiKrsomYDQ86MbiVy9XqGAqHzOS8JCh","news_summary":"SpacePharma mini-lab launched in Italy-Israel collaboration","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9ff659fd-84c7-45de-9a5c-700d6d8ecddc","date":"Feb 11, 2020","link":"https://www.mobihealthnews.com/news/europe/israeli-italian-collaboration-study-behaviour-antibacterial-materials-space?mkt_tok=eyJpIjoiTlRjeVkyWTVObVEwTldRNCIsInQiOiJldE12TVJJU3VVXC9JSzdRR0F6YkMwVmRySHFnQnFiWTh4Y1R1Y2U3WTYwQ1VCckVjRmRJRjJkY0hwNzkxSnBlRnNvUkhzY0RETG5aSGdEN1FOaW9oZnNNclFubUdBem5WemJPeHNHV0VTTGFVTlRVZ0k1WHVUbGk4d25QSWtlWTEifQ%3D%3D","source":"www.mobihealthnews.com","visible":1,"analysis":{"tags":"space research","company":"SpacePharma","layoffs":null,"summary":"Researchers from Israel and Italy are collaborating on a space project to examine the resistance of bacteria that cause human diseases. The study, planned for March, will see four experiments conducted remotely on a nanosatellite provided by Israeli company SpacePharma. The experiments aim to provide further insight into how antibiotic-resistant bacteria develop. Space research has become an area of increased exploration for medical research, with the goal of maintaining the health of astronauts. The collaboration between Israel and Italy in this experiment is seen as a significant business potential in the space economy.","partners":"University of Bologna, Israel’s Institute of Technology, Technion, Chaim Sheba Medical Center, Hebrew University","customers":null,"investors":null,"confidence":9,"key_topics":["space research","antibiotic-resistant bacteria","nanosatellite","telehealth","space economy"],"date_of_event":"March","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"rEp0s2GPycFhXDF8KEEyQbF9g3Uepv6CLXpXeKOw4eIckTk3nRjz0J","news_summary":"Israeli-Italian collaboration to study the behaviour of antibacterial materials in space","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"47587981-4b45-47ef-b166-02e1e7eeb203","date":"Oct 24, 2018","link":"http://www.thetower.org/6773oc-israeli-startup-allows-pharmaceutical-companies-to-develop-drugs-faster-in-space/","source":"www.thetower.org","visible":1,"analysis":{"tags":"pharmaceuticals, space experiments","company":"SpacePharma","layoffs":null,"summary":"Israeli-Swiss tech firm SpacePharma offers orbiting minilabs for conducting experiments in space at a fraction of the cost of traditional methods. The company has two minilabs in operation and plans to launch more in the future. Tests conducted in microgravity can provide valuable insights into the growth and reactions of bacteria, stem cells, and other substances. SpacePharma has raised $8 million in funding and is also developing its own intellectual property. The low cost of the minilabs opens up opportunities for individuals and small groups to conduct experiments, potentially leading to the development of orphan drugs for rare diseases. SpacePharma has partnerships with various space agencies and research organizations.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["space experiments","pharmaceuticals","microgravity","minilabs","cost savings"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2djejRHsfV5yU5AbuDayHGHl6l5d0S5M7f6tyB3WyDfHJm6ktAydoI","news_summary":"Israeli Startup Allows Pharmaceutical Companies to Develop Drugs Faster - In Space","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a54fcccd-4cea-42a7-b6b1-53e75f74e233","date":"Aug 17, 2016","link":"http://www.parabolicarc.com/2016/08/17/spacepharma-expands-united-states/","source":"www.parabolicarc.com","visible":1,"analysis":{"tags":"expansion","company":"SpacePharma SA","layoffs":null,"summary":"SpacePharma SA has expanded to the United States with the introduction of its wholly owned subsidiary, SpacePharma, Inc. The subsidiary will offer American research and pharmaceutical businesses access to microgravity services and solutions. SpacePharmas miniaturized laboratory, mGnify, will be available to U.S. customers, allowing them to perform advanced biological and chemical experiments remotely. The company has received its third round of funding through the Space Florida-Israel Innovation Partnership Program. SpacePharma aims to expand its presence in the United States to help more American customers use microgravity for research and development at an affordable price.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["microgravity","research","pharmaceutical","end-to-end laboratory","funding"],"date_of_event":"Q4 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"DSjhHAhxaIFfYefUTAf9bUYMFQeftgBCKViaJxezBcSsUAA0W1oh0W","news_summary":"SpacePharma Expands to United States","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5f83b633-0c5f-47e9-b623-9f276e3a43a4","date":"Aug 16, 2016","link":"http://spaceref.com/news/viewpr.html?pid=49298","source":"spaceref.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"3UclWLQsLI8WJ49oU0JMDEe9ACyZz587dXku7nR1PvRH3gZKXW4Yu7","news_summary":"SpacePharma SA launches American subsidiary, SpacePharma, Inc.","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"c50916b5-ed6e-4d09-96c0-1bcfa0d6ab52","date":"Feb 1, 2016","link":"http://cordis.europa.eu/project/rcn/203195_en.html","source":"cordis.europa.eu","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"TooE5WAzL2b3SGEKkDPSElcNyJmGhrncfTywHgFvDrpZha748wDWPj","news_summary":"SpacePharma Microgravity Miniature Pump  SPuMP Project  Fact Sheet  H2020  CORDIS  European Commission","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":8,"techcommunityinvolvement":null,"mediagallery":[{"id":"4d633b2c-d0c7-408a-b5ab-9ac2dffeb974","timestamp":"2020-09-07 12:05:33.000000","resources_type":1,"resources_title":"DIDO-3 ","resources_file_name":"$WIwyHYkcOqRP9izy1Nfy0wVoXwHFjk7WkhMgS31jVO89f2LYu5WHMe","alt":"DIDO-3  logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$WIwyHYkcOqRP9izy1Nfy0wVoXwHFjk7WkhMgS31jVO89f2LYu5WHMe","url":"https://storage.googleapis.com/clean-finder-353810/$WIwyHYkcOqRP9izy1Nfy0wVoXwHFjk7WkhMgS31jVO89f2LYu5WHMe"},{"id":"d04f3505-4870-4b96-9a2b-fa154567af6b","timestamp":"2020-08-20 00:16:48.000000","resources_type":2,"resources_title":"","resources_file_name":"itjEZ9Cf0N4","alt":"","imageurl":"https://img.youtube.com/vi/itjEZ9Cf0N4/0.jpg","url":"http://youtu.be/itjEZ9Cf0N4"}],"tags":["simulation","laboratories","biotechnology","pharmaceuticals","aerospace","pharma-companies","antibodies","microbiology","space-tech","cancer","stem-cells"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvavvYLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2G","B2B"],"productstage":"R&D","products":["SPuMP","SPAD","Corolab","uGnify"],"geomarkets":["Europe","United States","Switzerland","Israel"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":1,"lastfunding":"$2.37M","totalrounds":4,"fundingstage":"A","totalfunding":"$19.98M","publicinvestors":1,"lastpublicfunding":2370000,"totalpublicrounds":4,"totalpublicfunding":19980000},"team":[{"name":"Yossi Yamin","email":"yamin.yossi@space4p.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLGF-54IDA","bounced":true,"claimed":1,"founder":1,"urlname":"yossi-yamin","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAsd_EsAkM","position":"Co-founder & CEO SpacePharma SA","last_name":"Yamin","claimtoken":"614a084b7cd1d5c1a585e71dcdef41b8adf82ba0397ed4571d8f1c90f4cbcc7d","first_name":"Yossi","picturekey":"$gde1z3SZWEWLqUPYYMh1iUBAZcSUrRXdSpLEcRDc8LGfYCGkLs0Z1B","claimeddate":"2019-04-21","linkedinurl":"https://www.linkedin.com/in/yossi-yamin-88179752/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2019-04-21 15:16:48.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$gde1z3SZWEWLqUPYYMh1iUBAZcSUrRXdSpLEcRDc8LGfYCGkLs0Z1B","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Martin Aebi","email":"aebi.martin@space4p.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4NmT15YJDA","bounced":true,"claimed":0,"founder":1,"urlname":"martin-aebi","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg-cmQxQgM","position":"Co-founder & GM","last_name":"Aebi","claimtoken":"XnuYJx0MmtRUDBp1pK8Dh64U5wExTkvemCwgdtuZ2JuLS9RwWyM8po","first_name":"Martin","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/martinaebi/","unsubscribed":false,"is_activeuser":1,"additionalemail":"martin@space4p.com","claimedemaildate":"2022-12-18 20:23:02.000000","initials":"MA","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Daniel  Campbell","email":"campbell.daniel@spacepharma.health","phone":"","gender":"Male","userid":"ix5Ui52qzTsRlBYdzo4rWfl3p0SRRduyQk8ADKl1uHpJu6KZCVVLvr","bounced":false,"claimed":1,"founder":0,"urlname":"daniel-campbell-2","visible":1,"memberid":"hqBduKTpJsx4TPi6KiR3Cr8kQvQQK4UZxrqRtMnl3snVAIVGapjW0o","position":"CCO","last_name":"Campbell","claimtoken":"rfsXvLWrJloASkAPld4RKZHzlN9X2IEoRl4d2E9Ix1V0mUZTcJIn4G","first_name":"Daniel ","picturekey":null,"claimeddate":"2025-01-16","linkedinurl":"https://www.linkedin.com/in/danielcampbell/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2025-01-16 13:55:36.000000","initials":"DC","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Rami Dadoush","email":"dadoush.rami@space4p.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4LnukrgJDA","bounced":true,"claimed":0,"founder":0,"urlname":"rami-dadoush","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgmemWvwsM","position":"CFO","last_name":"Dadoush","claimtoken":"d17db2161cb576d2495fe7664c21bc3d5a5851c2d69add828d2aefed1f666d5a","first_name":"Rami","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"rami@space4p.com","claimedemaildate":null,"initials":"RD","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Paul  Kamoun","email":"kamoun.paul@space4p.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4Obc7YMJDA","bounced":true,"claimed":0,"founder":0,"urlname":"paul-kamoun","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg-piokwoM","position":"CMO","last_name":"Kamoun","claimtoken":"20d24d9a311e789368430ea3508db34673b1348536f6147eb0d6de743315f977","first_name":"Paul ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/paul-kamoun-42357219a/","unsubscribed":false,"is_activeuser":1,"additionalemail":"paul.kamoun@space4p.com","claimedemaildate":"2020-09-07 10:49:34.000000","initials":"PK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Life Sciences & HealthTech","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-04-03T00:00:00.000Z","crunchbaseid":"spacepharma","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":"Raz Zohar","creator_email":"raz@platterz.ca","createdate":"2014-10-14T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Sharon Shapira","affiliatedOrganizations":null,"timeline":[{"id":"bhyx7VGGPzZLaIRHlR6MlhbwMlmUpCMOheeLddfIqvdRO2rGcXWXy0","date":"Mar 2024","amount":"$2.37M","source":"","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"European Innovation Council","type":"Investor","amount":null,"hidden":false,"country":"Belgium","fullurl":"/investor_page/european-innovation-council","logokey":"$BM8t5Nw7HzAiqGbGUipDDhCefh8oinehng6mftX5R55QqxvAAyPLau","tagline":"","urlname":"/investor_page/european-innovation-council","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC7qIihCww","fundingtype":"Incubator","leadpartner":null,"investmentid":"Hzlp2aaFNBZfGGZkJzljJPQTmsErkseq0jVAL23hRAMo0CV2J1oyen","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BM8t5Nw7HzAiqGbGUipDDhCefh8oinehng6mftX5R55QqxvAAyPLau","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":2370000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"ucrCJcsY0qSK5UfVPVhLYcXNMTdw3PHwWCQlaXG17Cxi5rUDqEeUUo","date":"Aug 2018","amount":"$10M","source":"","eventtype":"FundingRoundEvent","investment":[{"name":"State of Mind Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/state-of-mind-ventures","logokey":"$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","tagline":null,"urlname":"/investor_page/state-of-mind-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOmArYULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"rqyAxx1iu3CKJ862PZIZJFpiWAXFeB9xB8tE4j9lcpn1tnIDAsujjs","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","leadcaption":"Lead ","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEvIzPCQw","date":"Jan 2015","amount":"$5M","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"State of Mind Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/state-of-mind-ventures","logokey":"$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","tagline":null,"urlname":"/investor_page/state-of-mind-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOmArYULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"46916d8f-811b-46bb-ad70-525ca60ced72","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","leadcaption":"","followupcaption":""},{"name":"Israeli Office of the Chief Scientist","type":"Other","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israeli-office-of-the-chief-scientist","logokey":null,"tagline":"","urlname":"/company_page/israeli-office-of-the-chief-scientist","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7s-uCQw","fundingtype":"Other","leadpartner":null,"investmentid":"9e5c4605-99f4-48f7-a788-3ae54db230d0","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","leadcaption":"","followupcaption":""},{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"fdbb4d49-6081-43b0-9424-132ce3d6e89c","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":1,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"a2giXelDxCQeBNcXSXO9eAQUV0pveGBHPqhQftZYLAu789nFQmvP9n","date":"Jan 2015","amount":"$2.61M","source":"","eventtype":"FundingRoundEvent","investment":[{"name":"State of Mind Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/state-of-mind-ventures","logokey":"$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","tagline":null,"urlname":"/investor_page/state-of-mind-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOmArYULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"j9ZAzNoULL6ZJuL8COgvEmNHRpyrfgWm6rIhbvZSCnImr7d2NQuTXi","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2610000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"6/2013","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"SpacePharma","logourl":"https://storage.googleapis.com/clean-finder-353810/$exvZr7H7eQqEObo1yyfvBbAV9CVDN9OnfOvtn0B420HTKUDe25gBgE","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$exvZr7H7eQqEObo1yyfvBbAV9CVDN9OnfOvtn0B420HTKUDe25gBgE","seoabout":"SpacePharma is focused on using microgravity, or virtual weightlessness, for research and development. The company has developed end-to-end miniaturized la...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":5,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Simulation & Imaging","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Industrial Manufacturing","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Discrete Industries","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA","classificationName":"targetcustomer"},{"depth":3,"name":"Aerospace","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvavvYLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA>Discrete Industries#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA>Aerospace#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvavvYLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA>Discrete Industries#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA","IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","TechnologyClassificationModel>Simulation & Imaging#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA|2:>IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA/Discrete Industries#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA|3:>IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA>Discrete Industries#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA/Aerospace#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvavvYLDA|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Simulation & Imaging#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Industrial Manufacturing","key":"0-0","path":"IndustryClassificationModel>Industrial Manufacturing","children":[{"title":"Discrete Industries","key":"0-0-0","path":"IndustryClassificationModel>Industrial Manufacturing>Discrete Industries","children":[{"title":"Aerospace","key":"0-0-0-0","path":"IndustryClassificationModel>Industrial Manufacturing>Discrete Industries>Aerospace"}]}]},{"title":"Healthcare & Life Sciences","key":"0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-1-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Simulation & Imaging","key":"0-0","path":"TechnologyClassificationModel>Simulation & Imaging"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Simulation & Imaging","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvn0O8LDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Industrial Manufacturing","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Discrete Industries","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvppskJDA","classificationName":"targetcustomer"},{"depth":3,"name":"Aerospace","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvavvYLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Simulation & Imaging"],"targetCustomer":["Industrial Manufacturing","Discrete Industries","Aerospace","Healthcare & Life Sciences","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"ucrCJcsY0qSK5UfVPVhLYcXNMTdw3PHwWCQlaXG17Cxi5rUDqEeUUo","date":"Aug 2018","amount":"$10M","source":"","eventtype":"FundingRoundEvent","investment":[{"name":"State of Mind Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/state-of-mind-ventures","logokey":"$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","tagline":null,"urlname":"/investor_page/state-of-mind-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOmArYULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"rqyAxx1iu3CKJ862PZIZJFpiWAXFeB9xB8tE4j9lcpn1tnIDAsujjs","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","leadcaption":"Lead ","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"a2giXelDxCQeBNcXSXO9eAQUV0pveGBHPqhQftZYLAu789nFQmvP9n","date":"Jan 2015","amount":"$2.61M","source":"","eventtype":"FundingRoundEvent","investment":[{"name":"State of Mind Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/state-of-mind-ventures","logokey":"$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","tagline":null,"urlname":"/investor_page/state-of-mind-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOmArYULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"j9ZAzNoULL6ZJuL8COgvEmNHRpyrfgWm6rIhbvZSCnImr7d2NQuTXi","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2610000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"bhyx7VGGPzZLaIRHlR6MlhbwMlmUpCMOheeLddfIqvdRO2rGcXWXy0","date":"Mar 2024","amount":"$2.37M","source":"","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"European Innovation Council","type":"Investor","amount":null,"hidden":false,"country":"Belgium","fullurl":"/investor_page/european-innovation-council","logokey":"$BM8t5Nw7HzAiqGbGUipDDhCefh8oinehng6mftX5R55QqxvAAyPLau","tagline":"","urlname":"/investor_page/european-innovation-council","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC7qIihCww","fundingtype":"Incubator","leadpartner":null,"investmentid":"Hzlp2aaFNBZfGGZkJzljJPQTmsErkseq0jVAL23hRAMo0CV2J1oyen","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BM8t5Nw7HzAiqGbGUipDDhCefh8oinehng6mftX5R55QqxvAAyPLau","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":2370000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEvIzPCQw","date":"Jan 2015","amount":"$5M","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"State of Mind Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/state-of-mind-ventures","logokey":"$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","tagline":null,"urlname":"/investor_page/state-of-mind-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOmArYULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"46916d8f-811b-46bb-ad70-525ca60ced72","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mqYSoem0b44uFy4ZAhyGbTfnmgd5BZjVU8ByLnrEULom3Eyvpdp8Ag","leadcaption":"","followupcaption":""},{"name":"Israeli Office of the Chief Scientist","type":"Other","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israeli-office-of-the-chief-scientist","logokey":null,"tagline":"","urlname":"/company_page/israeli-office-of-the-chief-scientist","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7s-uCQw","fundingtype":"Other","leadpartner":null,"investmentid":"9e5c4605-99f4-48f7-a788-3ae54db230d0","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","leadcaption":"","followupcaption":""},{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"fdbb4d49-6081-43b0-9424-132ce3d6e89c","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":1,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}